ArticleInternational journal of surgery (London, England)2025

Recombinant human type-5 adenovirus (H101) combined with radiofrequency ablation versus traditional radiofrequency ablation for hepatocellular carcinoma ≤ 3 cm: a phase III randomized controlled trial.

Hai-Su Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.